Search Within

Daniel C Danila

  1. "2015"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Department of Medicine (9)
  2. Genitourinary Oncology Service (9)
  3. Solid Tumor Oncology Division (9)
  4. Epidemiology and Biostatistics (2)
  5. GSK Faculty (2)
  6. Hematologic Malignancies, Division of (2)

More Groups

People
  1. Howard Scher (8)
  2. Martin Fleisher (5)
  3. Dana Rathkopf (4)
  4. Michael Morris (4)
  5. Nicole Schreiber (4)
  6. Kristen Curtis (3)

More People

Years
  1. 2015 (9)
Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (1)
  3. Clinical Genitourinary Cancer (1)
  4. Journal of Nuclear Medicine (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Society of Nuclear Medicine (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictive biomarkers of tumor sensitivity to STEAP1 antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Scher, H. I.; Szafer-Glusman, E.; Herkal, A.; Suttmann, R.; Fleisher, M.; Schreiber, N. A.; Curtis, K.; Gilbert, H.; Maslyar, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Wholebody clearance of three (89)Zr labeled antibodies: Differences between PET based and whole body probe based clearance
    Meeting Abstract

    Beylergil, V.; Pandit-Taskar, N.; Larson, S.; Morris, M.; Danila, D. C.; Bander, N.; Fine, B.; Carrasquillo, J.; Weber, W.; O'Donoghue, J.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Intra-patient genomic heterogeneity of single circulating tumor cells (CTCs) associated to phenotypic CTC heterogeneity in metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Landers, M.; Greene, S.; Schreiber, N. A.; Rodriguez, A.; Bambury, R. M.; Danila, D. C.; Rathkopf, D. E.; Fleisher, M.; Louw, J.; Jendrisak, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide post-chemotherapy (phase 3 AFFIRM study)
    Meeting Abstract

    Fleisher, M.; Danila, D. C.; Fizazi, K.; Hirmand, M.; Selby, B.; Phung, D.; de Bono, J. S.; Scher, H. I.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Fleisher, M.; Carrasquillo, J. A.; Gilbert, H.; Morris, M. J.; Bellomo, L. P.; Hendrikx, P. J.; Szafer-Glusman, E.; Herkal, A.; Patel, C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Curtis, K. R.; Taylor, B. S.; Arcila, M. E.; Brennan, R.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Predictive biomarkers of sensitivity to androgen receptor signaling (ARS) and taxane-based chemotherapy in circulating tumor cells (CTCs) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Scher, H. I.; Louw, J.; Jendrisak, A.; Bambury, R. M.; Danila, D. C.; Rathkopf, D. E.; Arslan, Z.; Schreiber, N. A.; Lu, D.; Krupa, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Severe hypocalcemia associated with denosumab in metastatic castration-resistant prostate cancer: Risk factors and precautions for treating physicians
    Journal Article

    Autio, K. A.; Farooki, A.; Glezerman, I. G.; Chan, A.; Schneider, C. W.; Barr, H. C.; Seyboth, B. M.; Kampel, L. J.; Danila, D. C.; Rathkopf, D. E.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer
    Journal Article

    Scher, H. I.; Heller, G.; Molina, A.; Attard, G.; Danila, D. C.; Jia, X.; Peng, W.; Sandhu, S. K.; Olmos, D.; Riisnaes, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save